Adents to host series of global serialisation innovation summits

Partners to include leading tech companies and organisations to share expertise in the life science industry, with forums planned for Paris, Philadelphia and Shanghai

Adents, a leading provider of premier, versatile serialisation and track & trace solutions, is planning a series of serialisation conferences in Paris (5-6 April), Philadelphia (June) and Shanghai (October).

The series of educational forums will include presentations from leading tech companies, including Microsoft and Siemens, as well as government entities overseeing the push for track & trace implementation, such as GS1, the Healthcare Distribution Alliance (HDA), European Medicines Verification Organisation (EMVO) and high-level consulting firms.

The programmes will focus on serialisation solutions that allow global pharmaceutical companies, CMOs and Trading Partners to transform their operations in a positive way

The programs for each event will be wholly innovative and tech-driven, focusing on forward-thinking serialisation solutions that allow global pharmaceutical companies, CMOs and Trading Partners to transform their operations in a positive way. The educational gatherings will look beyond the looming mandates, by demonstrating how manufacturing and supply chain pharma companies can utilise the troves of data generated during the serialisation process to improve production and supply chain efficiencies.

Considering this, the series of forums will include presentations and roundtable discussions covering a variety of tech-related topics, including data security & blockchain, simplified interconnectivity, artificial intelligence, virtual glasses and virtual automation.

"Our upcoming conference series presents an opportunity to connect Big Pharma manufacturers and their supply chain trading partners – including 3PLs, distributors, hospitals, retailers and other serialisation stakeholders – with communications standard influencers and technology leaders," explained Christophe Devins, CEO of Adents.

Focus on Emerging, Disruptive Technologies

The event series’ overarching theme is technology. Adents takes a long-term approach to innovation, investing heavily in research and collaboration with best-in-class leaders to identify technology’s impact on the pharmaceutical industry. These efforts deal not only with the various spectrum of serialisation initiatives currently affecting markets around the world, but also the increasing demand for more automated production and business improvement methods.

Executives from Siemens and Microsoft will discuss industry trends, present real-life challenge/solution scenarios, and share expertise on implementing comprehensive track & trace programs

The forums also will reinforce Adents’ leadership position by emphasising several high-profile partnerships. For example, executives from Siemens and Microsoft will discuss industry trends, present real-life challenge/solution scenarios, and share expertise on implementing comprehensive track & trace programs.

“Serialisation is a new frontier for the pharma industry, where data security will be key. Blockchain technology and cloud architecture will be must-haves for serialisation data owners all along the supply chain,” said Franck Goron, Senior Digital Advisor at Microsoft.

Registration information for the Adents Global Serialization Innovation Summits will be available in the coming weeks (www.adents.com). To allow for networking between attendees, each conference will be limited to 250 participants.

Companies